Elanco Animal Health Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is Joe Modisett. I lead our health care investment banking effort in the U.S. It's great today that we have Elanco with us. We have Jeff Simmons, President and CEO. And before we jump into Q&A, I'm going to read some of the standard disclosures here. So for important disclosures, please see the Morgan Stanley research disclosure website, www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
So Welcome, Jeff. You've been quite busy here over since the IPO. And I thought maybe it's just as we start, obviously, there's been a lot of changes to your business. Obviously, you stood up the business coming out of Lilly. You've done a number of major strategic deals, Bayer being the most -- the largest and probably the most important. A lot of operational changes, whether it be channel strategy or productivity
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
